查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1195586

高級可視化市場——增長、趨勢、COVID-19 影響和預測 (2023-2028)

Advanced Visualization Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，高級可視化市場預計將以 11.3% 的複合年增長率增長。

COVID-19 大流行對市場產生了重大影響。 在大流行期間，胸部計算機斷層掃描 (CT) 掃描被認為是識別 COVID 感染的最有效的非侵入性方法之一。

主要亮點

  • 波蘭放射學雜誌 2022 年 1 月發表的一篇報告顯示，COVID-19 肺炎和非 COVID-19 肺炎具有不同的胸部計算機斷層掃描 (CT) 特徵。我來了。 因此，它是診斷新型冠狀病毒病 (COVID-19) 的流行工具。 因此，對高級可視化的需求很高，預計會對市場產生重大影響。 目前，COVID-19病例相對較少，預計COVID-19將導致被調查市場穩步增長。
  • 市場增長的主要驅動因素包括慢性病患病率上升、人口老齡化以及人們越來越意識到先進的可視化工具在疾病診斷中的好處。 根據 Dementia Australia Ltd 在 2022 年發布的一份報告，估計有 487,500 名澳大利亞人患有癡呆症，預計到 2058 年這一數字將增加到約 110 萬。 隨著人們年齡的增長，癡呆症變得更加普遍。 由於老年人更容易患癡呆症，全球老齡化人口不斷增加，市場有望擴大。 因此，癡呆等慢性疾病可以通過放射學檢查來診斷，其中先進的可視化技術發揮著重要作用，有望引領市場。
  • 據世界衛生組織稱，到 2050 年，全球 60 歲及以上人口將翻一番，達到 21 億。 隨著人口老齡化的加劇，各種慢性病患者的數量預計會增加，先進的可視化工具有望提高患者的正確診斷率。 因此，市場有望實現高增長。
  • 但是，診斷放射學的有限報銷可能會限制市場。

高級可視化市場趨勢

預計在預測期內腫瘤臨床應用將增長

  • 腫瘤學成像主要用於早期檢測（例如轉移的出現），以阻止或預防全面發展的疾病。 同樣，在腫瘤學中，成像對於有效的放射治療很重要。 因此，圖像處理中的高級可視化技術可幫助醫生儘早診斷癌症。 推動市場增長的主要因素包括不斷提高的技術進步和越來越多地在醫療機構中採用先進的可視化工具。
  • 此外，預計在預測期內，各種類型癌症患病率的上升將推動對高級可視化系統的需求。 根據美國癌症協會“2022 年癌症事實與數據”，到 2040 年，全球癌症負擔估計將達到 2800 萬新癌症病例，這完全是由於人口增長和老齡化。。 因此，診斷成像的需求不斷增長，需要先進的可視化技術來提供準確、高質量的圖像。
  • 此外，市場參與者正在向市場推出新產品。 例如，2021 年 11 月，飛利浦在 2021 年北美放射學會 (RSNA) 上推出了新的支持 AI 的 MR7700 3.0T 系統。 它具有最高質量擴散成像和高級神經科學測序的多核臨床能力。 因此，考慮到上述所有因素，市場有望在預測期內增長。

預計在預測期內北美將佔據重要的市場份額

  • 由於慢性病病例不斷增加和醫療保健基礎設施的改善，預計北美將在全球高級可視化市場中佔據主要市場份額。 此外，老年人口的增加增加了該地區患慢性病的風險，這將推動研究期間的市場增長。
  • 根據加拿大統計局的數據，2021 年和 2022 年 65 歲及以上的人口數量將分別為 7,081,750 和 7,329,910。 同樣，阿爾茨海默病協會在 2022 年發布的一份報告估計，2031 年加拿大將有 100 萬人患有癡呆症，2050 年將有近 200 萬人。 因此，老年人口的增加以及慢性病的增加將增加對診斷成像的需求，其中先進的可視化技術起著關鍵作用，並且市場有望在預測期內擴大。
  • 此外，在研究期間，高級可視化平台的新進展以及新批准和發布正在推動市場增長。 例如，2021 年 11 月，總部位於聖地亞哥的人工智能和可視化醫療平台 LifeVoxel.AI 籌集了 500 萬美元的種子資金。 LifeVoxel 的專利技術能夠以零延遲、零客戶端足跡即時和無處不在地訪問交互式圖像研究和數據，並以 4K 質量呈現它們。
  • 因此，由於上述因素，北美市場有望在預測期內實現增長。

高級可見性市場競爭對手分析

高級可視化市場適度整合。 高級可視化市場的市場參與者包括 Agfa-Gevaert Group、Canon Inc.（佳能醫療系統公司）、Carestream Health、Fujifilm Holdings Corporation、通用電氣公司（GE Healthcare）、Koninklijke Philips NV、Pro Medicus Ltd、Siemens Healthcare GmbH , 和 Terarecon Inc.

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 慢性病患病率隨著老年人口的增加而增加
    • 越來越意識到高級可視化工具在疾病診斷中的優勢
  • 市場製約因素
    • 基於輻射的診斷程序的報銷限制
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（價值基礎，市場規模：100 萬美元）

  • 按產品/服務
    • 硬件
    • 軟件
    • 按服務
  • 按解決方案類型
    • 企業
    • 獨立的
  • 通過成像方式
    • 磁共振成像 (MRI)
    • 計算機斷層掃描 (CT)
    • 超聲診斷設備
    • 核醫學
    • 其他成像方式
  • 通過申請
    • 腫瘤科
    • 骨科
    • 心髒病學
    • 神經
    • 其他臨床應用
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Agfa-Gevaert Group
    • Canon Inc.（Canon Medical Systems Corporation）
    • Carestream Health
    • Fujifilm Holdings Corporation
    • General Electric Company（GE Healthcare）
    • Koninklijke Philips NV
    • Pro Medicus Ltd
    • Siemens Healthcare GmbH
    • Terarecon Inc.

第7章 市場機會今後動向

簡介目錄
Product Code: 57051

The advanced visualization market is expected to register a CAGR of 11.3% over the forecast period. The COVID-19 pandemic had a significant impact on the market. During the pandemic, chest computed tomography (CT) scans were regarded as one of the most effective non-invasive methods for identifying COVID infections.

Key Highlights

  • As per the report published by the Polish Journal of Radiology in January 2022, COVID-19 pneumonia and pneumonia without COVID-19 have different chest computed tomography (CT) characteristics. Hence, it was a commonly used tool for the diagnosis of the novel coronavirus disease (COVID-19). Thus, the demand for advanced visualization was high and expected to impact the market significantly. Currently, the cases of COVID-19 are relatively less, and it is expected to have stable growth in the studied market due to COVID-19.
  • The major factors for the growth of the market include the increasing prevalence of chronic diseases coupled with the growing geriatric population and rising awareness of the benefits associated with advanced visualization tools in disease diagnosis. According to the report published by Dementia Australia Ltd in 2022, an estimated 487,500 Australians are living with dementia, and it is expected to increase to almost 1.1 million by 2058. Dementia is more common as people grow older. The growing geriatric population worldwide is anticipated to increase the market since an aged population is more susceptible to dementia. Hence, chronic diseases like dementia can be diagnosed with radiology, where advanced visualization plays a major role and is expected to drive the market.
  • According to the WHO, by 2050, the world's population of people aged 60 years and older will double to 2.1 billion. The rise in the geriatric population will increase the patient pool suffering from various chronic diseases, and advanced visualization tools are expected to increase the correct diagnosis rate among patients. Hence, the market is expected to witness high growth.
  • However, the limited availability of reimbursements for radiology-based diagnostic procedures may restrain the market.

Advanced Visualization Market Trends

Oncology Under Clinical Application Expected to Grow Over the Forecast Period

  • Imaging in oncology is mostly used for early detection, such as the appearance of metastases, to allow for the interception or prevention of full-blown disease. Similarly, in oncology, imaging is crucial for the effective delivery of radiation treatment. Hence, advanced visualization technology in imaging help physicians to diagnose cancers in the earliest stage possible. The major factors driving the growth of the market include rising technological advancements and an increase in the adoption of advanced visualization tools in healthcare facilities.
  • Furthermore, the rising prevalence of various types of cancer is expected to boost the demand for advanced visualization systems over the forecast period. According to the American Cancer Society, Cancer Facts & Figures 2022, it is estimated that by 2040, the global burden of cancer is expected to reach 28.0 million new cancer cases solely due to the growth and aging of the population. As a result, there is a greater need for diagnostic imaging, which requires sophisticated visualization to provide accurate and high-quality images.
  • Moreover, major market players are launching new products in the market. For instance, in November 2021, Philips launched a new AI-enabled MR 7700 3.0T system in the Radiological Society of North America (RSNA) 2021. It has multinuclear clinical capabilities to deliver the highest quality diffusion imaging and advanced neuroscience sequences. Thus, considering all the above-mentioned factors, the market is expected to grow over the forecast period.

North America Expected to hold a Significant Market Share Over the Forecast Period

  • North America is expected to hold a major market share in the global advanced visualization market due to increasing cases of chronic diseases and the presence of better healthcare infrastructure. Furthermore, the growing geriatric population increases the risk of chronic diseases in the region, which drives the market growth during the study period.
  • According to Statistics Canada, the number of persons aged 65 years and older in 2021 and 2022 is 7,081,750 and 7,329,910, respectively. Similarly, as per the report published by the Alzheimer Society in 2022, it is estimated that by 2031, 1 million people and by 2050, nearly 2 million people in Canada will be living with dementia. Hence the growing geriatric population, along with the rise in chronic diseases, increases the demand for diagnostic imaging where advanced visualization technology plays an important role and thus is expected to grow the market over the forecast period.
  • Moreover, the new advancements, along with the new approvals and launches in advanced visualization platforms, help the market to grow during the study period. For instance, in November 2021, LifeVoxel.AI, a San Diego-based medical platform for AI and Visualization, raised USD 5 million in seed funding. LifeVoxel's patented technologies empower instant and ubiquitous access to interactive imaging studies and data with zero latency and zero client footprint, rendering them at 4K image quality.
  • Thus, owing to the abovementioned factors, the North American segment is expected to grow the market over the forecast period.

Advanced Visualization Market Competitor Analysis

The advanced visualization market is moderately consolidated. Some of the market players in the advanced visualization market are Agfa-Gevaert Group, Canon Inc. (Canon Medical Systems Corporation), Carestream Health, Fujifilm Holdings Corporation, General Electric Company (GE Healthcare), Koninklijke Philips NV, Pro Medicus Ltd, Siemens Healthcare GmbH, and Terarecon Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic Diseases Coupled With Growing Geriatric Population
    • 4.2.2 Rising Awareness of Benefits associated with Advanced Visualization Tools in Disease Diagnosis
  • 4.3 Market Restraints
    • 4.3.1 Limited Availability of Reimbursements for Radiology-Based Diagnostic Procedures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product and Service
    • 5.1.1 Hardware
    • 5.1.2 Software
    • 5.1.3 Services
  • 5.2 By Type of Solution
    • 5.2.1 Enterprise
    • 5.2.2 Standalone
  • 5.3 By Imaging Modality
    • 5.3.1 Magnetic Resonance Imaging (MRI)
    • 5.3.2 Computed Tomography (CT)
    • 5.3.3 Ultrasound
    • 5.3.4 Nuclear Medicine
    • 5.3.5 Other Imaging Modalities
  • 5.4 By Clinical Application
    • 5.4.1 Oncology
    • 5.4.2 Orthopedics
    • 5.4.3 Cardiovascular
    • 5.4.4 Neurology
    • 5.4.5 Other Clinical Applications
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agfa-Gevaert Group
    • 6.1.2 Canon Inc. (Canon Medical Systems Corporation)
    • 6.1.3 Carestream Health
    • 6.1.4 Fujifilm Holdings Corporation
    • 6.1.5 General Electric Company (GE Healthcare)
    • 6.1.6 Koninklijke Philips NV
    • 6.1.7 Pro Medicus Ltd
    • 6.1.8 Siemens Healthcare GmbH
    • 6.1.9 Terarecon Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS